Dulaglutide treatment results in effective glycaemic control in latent autoimmune diabetes in adults (LADA): A post-hoc analysis of the AWARD-2, -4 and -5 Trials.
Paolo PozzilliRichard D LeslieAnne L PetersRaffaella BuzzettiSudha S ShankarZvonko MilicevicImre PavoJeremie LebrecSherry MartinNanette C SchlootPublished in: Diabetes, obesity & metabolism (2018)
These data are the first to indicate that dulaglutide was effective in reducing HbA1c in LADA patients.